Perfinity iDP System
Shimadzu introduces the Perfinity iDP (integrated Digestion Platform) system.
Perfinity iDP System
Shimadzu introduces the Perfinity iDP* (integrated Digestion Platform) system. This online enzyme digestion HPLC system fully automates all processes from the enzymatic digestion of protein samples to the HPLC analysis of digested peptides.
The Perfinity iDP uses a high-efficiency immobilized trypsin column for the online enzymatic digestion of proteins, it permits the online enzymatic digestion of proteins in less than one minute. The system iDP improves the analysis throughput by performing parallel processing of the stages from trypsin digestion to concentration in the desalting column and the stages from elution out of the desalting column to HPLC analysis.
The easy-to-use software supports method creation and selection for the series of processes from trypsin digestion to desalting and HPLC analysis.
An LC/MS can be added as a detector to automate the entire process up to analysis. Compared to conventional manual operations, the iDP offers more uniform control across the board and improves accuracy.
For more information please visit www.shimadzu.eu.
* Perfinity iDP is a registered trademark of Perfinity Biosciences, Inc.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
